Literature DB >> 16231288

Reconstitution of the lymphocyte compartment after lymphocyte depletion: a key issue in clinical immunology.

Frances T Hakim1, Ronald E Gress.   

Abstract

Loss of existing T cell populations is a significant clinical problem following cytoreductive therapies or in disease states such as HIV. Characterization of the pathways of T cell regeneration, their limitations and regulation, is central to the development of new approaches for the correction of T cell lymphopenia. Recently, there has been an increasing appreciation that subsets of T cells differ not only in requirements for homeostasis, but in the mechanisms of initial generation and later reconstitution of lost populations. In this issue, Cox et al. determine that variations in cytokine/chemokine levels may affect the biology of T cell recovery which impacts on the development of treatment strategies for lymphopenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231288     DOI: 10.1002/eji.200535385

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Lymphoid reconstruction and vaccines.

Authors:  Ronald E Gress; Krishna V Komanduri; Hermann Einsele; Laurence J N Cooper
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

2.  Perspective on potential clinical applications of recombinant human interleukin-7.

Authors:  Claude Sportès; Ronald E Gress; Crystal L Mackall
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

Review 3.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

4.  Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.

Authors:  Miriam E Mossoba; Masanori Onda; Justin Taylor; Paul R Massey; Shirin Treadwell; Elad Sharon; Raffit Hassan; Ira Pastan; Daniel H Fowler
Journal:  Clin Cancer Res       Date:  2011-04-26       Impact factor: 12.531

Review 5.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

Review 6.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

7.  Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.

Authors:  Nancy M Hardy; Frances Hakim; Seth M Steinberg; Michael Krumlauf; Romana Cvitkovic; Rebecca Babb; Jeanne Odom; Daniel H Fowler; Ronald E Gress; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2007-07-16       Impact factor: 5.742

Review 8.  From murine to human nude/SCID: the thymus, T-cell development and the missing link.

Authors:  Rosa Romano; Loredana Palamaro; Anna Fusco; Leucio Iannace; Stefano Maio; Ilaria Vigliano; Giuliana Giardino; Claudio Pignata
Journal:  Clin Dev Immunol       Date:  2012-03-05

9.  Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide.

Authors:  Susannah Ellsworth; Ani Balmanoukian; Ferdynand Kos; Christopher J Nirschl; Thomas R Nirschl; Stuart A Grossman; Leo Luznik; Charles G Drake
Journal:  Oncoimmunology       Date:  2014-01-03       Impact factor: 8.110

10.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.